Literature DB >> 16344588

Interferon-beta plus ribavirin for patients with hepatitis C virus genotype 1: a randomised pilot trial.

M Enomoto, A Tamori, N Kawada, H Jomura, S Nishiguchi, T Saibara, S Onishi, S Mochida, K Fujiwara.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16344588      PMCID： PMC1856396          DOI： 10.1136/gut.2005.081935

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  5 in total

1.  The science, economics, and effectiveness of combination therapy for hepatitis C.

Authors:  G Dusheiko; E Barnes; G Webster; S Whalley
Journal:  Gut       Date:  2000-08       Impact factor: 23.059

2.  Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays.

Authors:  S D Der; A Zhou; B R Williams; R H Silverman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

Review 3.  Monitoring of viral levels during therapy of hepatitis C.

Authors:  Gary L Davis
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

4.  Differential use of the betaL subunit of the type I interferon (IFN) receptor determines signaling specificity for IFNalpha2 and IFNbeta.

Authors:  P Domanski; O W Nadeau; L C Platanias; E Fish; M Kellum; P Pitha; O R Colamonici
Journal:  J Biol Chem       Date:  1998-02-06       Impact factor: 5.157

5.  A pilot study of ribavirin and interferon beta for the treatment of chronic hepatitis C.

Authors:  S Kakumu; K Yoshioka; T Wakita; T Ishikawa; M Takayanagi; Y Higashi
Journal:  Gastroenterology       Date:  1993-08       Impact factor: 22.682
  5 in total
  2 in total

1.  Long-Term Prognostic Factors after Hepatic Resection for Hepatitis C Virus-Related Hepatocellular Carcinoma, with a Special Reference to Viral Status.

Authors:  Masaki Koda; Shogo Tanaka; Shigekazu Takemura; Hiroji Shinkawa; Masahiko Kinoshita; Genya Hamano; Tokuji Ito; Norifumi Kawada; Toshihiko Shibata; Shoji Kubo
Journal:  Liver Cancer       Date:  2018-03-13       Impact factor: 11.740

2.  Successful natural interferon-β plus ribavirin therapy in a chronic hepatitis C patient after discontinuation of interferon-α treatment due to arrhythmia and interstitial pneumonia.

Authors:  Akira Sato; Masahiro Yamauchi; Takayuki Yamada; Reiko Kumano; Kayo Adachi; Toshiya Ishii; Mikihito Hayashi; Daisuke Kumon
Journal:  Clin J Gastroenterol       Date:  2014-06-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.